GB0901837D0 - Cancer diagnosis and treatment - Google Patents
Cancer diagnosis and treatmentInfo
- Publication number
- GB0901837D0 GB0901837D0 GBGB0901837.5A GB0901837A GB0901837D0 GB 0901837 D0 GB0901837 D0 GB 0901837D0 GB 0901837 A GB0901837 A GB 0901837A GB 0901837 D0 GB0901837 D0 GB 0901837D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- cancer diagnosis
- diagnosis
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0901837.5A GB0901837D0 (en) | 2009-02-05 | 2009-02-05 | Cancer diagnosis and treatment |
EP10706706A EP2393498A1 (en) | 2009-02-05 | 2010-02-05 | Cancer diagnosis and treatment |
PCT/GB2010/000204 WO2010089559A1 (en) | 2009-02-05 | 2010-02-05 | Cancer diagnosis and treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0901837.5A GB0901837D0 (en) | 2009-02-05 | 2009-02-05 | Cancer diagnosis and treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0901837D0 true GB0901837D0 (en) | 2009-03-11 |
Family
ID=40469583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0901837.5A Ceased GB0901837D0 (en) | 2009-02-05 | 2009-02-05 | Cancer diagnosis and treatment |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2393498A1 (en) |
GB (1) | GB0901837D0 (en) |
WO (1) | WO2010089559A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2601212A1 (en) * | 2010-08-04 | 2013-06-12 | Cizzle Biotechnology Limited | Methods and compounds for the diagnosis and treatment of |
GB201518466D0 (en) * | 2015-10-19 | 2015-12-02 | Cizzle Biotechnology Ltd | Use |
WO2019079914A1 (en) * | 2017-10-23 | 2019-05-02 | 蔡胜和 | Anti-ciz1 antibody |
CN108796083B (en) * | 2018-06-25 | 2021-03-19 | 山东大学 | Application of CIZ1 as molecular marker for diagnosing and treating tongue hemangioma |
CN114410780A (en) * | 2021-12-30 | 2022-04-29 | 武汉科技大学 | Application of KIF4A in diagnosis, prognosis and treatment of breast cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0228337D0 (en) * | 2002-12-05 | 2003-01-08 | Yorkshire Cancer Res Campaign | Replication protein |
-
2009
- 2009-02-05 GB GBGB0901837.5A patent/GB0901837D0/en not_active Ceased
-
2010
- 2010-02-05 EP EP10706706A patent/EP2393498A1/en not_active Withdrawn
- 2010-02-05 WO PCT/GB2010/000204 patent/WO2010089559A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010089559A1 (en) | 2010-08-12 |
EP2393498A1 (en) | 2011-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0922085D0 (en) | Cancer diagnosis and treatment | |
HK1175476A1 (en) | Cancer treatment | |
IL218575A0 (en) | Treatment of cancer | |
ZA201207574B (en) | Phytocannabinoids in the treatment of cancer | |
EP2629736A4 (en) | Tissue treatment | |
EP2332459A4 (en) | Medical treatment system | |
EP2412297A4 (en) | Cover type endoscope for treatment and cover for endoscope | |
EP2606349A4 (en) | Cancer diagnostic and cancer therapeutic | |
EP2412328A4 (en) | Medical treatment device | |
EP2340851A4 (en) | Diagnosis method and therapeutic method for cancer | |
IL214133A0 (en) | Skin treatment | |
GB0918392D0 (en) | Diagnostic and therapeutic methods | |
IL240560A0 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
IL221035A0 (en) | Cancer diagnosis and imaging | |
IL222958A0 (en) | Cancer treatment | |
GB0900599D0 (en) | Treatment | |
EP2420515A4 (en) | Diagnosis and treatment of cancer using anti-tmprss11e antibody | |
GB0901837D0 (en) | Cancer diagnosis and treatment | |
EP2361317A4 (en) | Use of eif3m for the diagnosis and treatment of cancer | |
PT2630475T (en) | Diagnostic method and treatment | |
EP2438167A4 (en) | Therapeutic and diagnostic molecules | |
ZA201203286B (en) | Therapeutic and diagnostic applications against trypanosomosis | |
EP2403341A4 (en) | Lung cancer treatment | |
EP2384370A4 (en) | Use of id4 for diagnosis and treatment of cancer | |
GB0916686D0 (en) | Treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |